Researchers aim to prevent Alzheimer's

Darrell Mousseau’s search for ways to delay the onset of Alzheimer’s disease, or even prevent it, got a boost Sept. 25 with the announcement of $1.6 million in government funding for the purchase of neuroimaging equipment.

By Mark Ferguson

Mousseau, associate professor of psychiatry in the College of Medicine and Saskatchewan Research Chair in Alzheimer's Disease and Related Dementias, leads a research team that will use the neuroimaging equipment to identify changes in brain chemistry that may trigger Alzheimer's. The results of the two-year project, supported by the Governments of Canada and Saskatchewan, are expected to lead to the development of new ways – perhaps a drug or vaccine – to arrest the disease before onset or even block its progress in patients already diagnosed with Alzheimer's.

The funding announcement was made in Regina during the annual conference of the Alzheimer Society of Saskatchewan. The Alzheimer Society and Saskatchewan Health Research Foundation also provide funding the ongoing work of Mousseau's team, which includes members from the College of Medicine, College of Pharmacy and Nutrition and VIDO-InterVac.